Innovative Drug Research and Development in Russia

Speakers & Panelists:

• Sergey Tsyb, Director of the Chemical and Technological Complex and Bioengineering Technologies, Ministry of Industry and Trade of the RF
• Jeroen Tonnaer, Senior Director, External Scientific Affairs, Worldwide Licensing, Benelux, Russia, Israel, South Africa, MSD
• Michael Engsig, Head of Russian Innovation Center, Nycomed
• Mikhail Fedorenko, Head of Division for Innovations and High-Tech, Vnesheconombank
• Anton Titov, Director, Investment Department, Skolkovo Foundation
• Maria Myagkikh, Head of R&D in Russia, Amgen
• Irina Dorokhova, Senior Director Government Affairs for Russia and CEE, Johnson&Johnson
• Anna Bazhenova, External Affairs Director, Janssen Pharmaceuticals
• Beatrice Shepherd, Vice President | CEE, Russia & CIS, Frost & Sullivan
• Dmitry Ovchinnikov, Medical Director, Sandoz
• Dmitry Pakhomov, New Business Development Director, Russia & CIS, Janssen Pharmaceuticals
• Irina Rogova, Head of the Department of Organization Preclinical and Clinical Trials, First Moscow State Medical University n.a. I.M. Sehenov
• Mihail Putilovsky, Head of Clinical Trials Department, Materia Media Holding
• Olga Orekhova, Medical Director, Johnson & Johnson
• Sergey Tyulyandin, Deputy Director of Institute of Clinical Oncology, Blokhin's Oncocenter 

WHAT TO EXPECT FROM THE FORUM IN 2011?
This event will take place over 2 days. While creating our event programme we have taken into account the wishes, requirements and requests that were put to us during our market research. More than 40 speakers, drawn from the most respected managers of the leading Russian and international pharma companies, representatives of state authorities, financiers, CRO’s and consultants will discuss in detail the most important issues regarding development of the sector in the current market conditions.